To explore protective mechanisms, we assessed organ injury markersplasma alanine aminotransferase (ALT) for liver injury and blood urea nitrogen (BUN) for kidney damageand found no significant differences between HCD- and RD-fed mice at 4, 20, and 44 hours post-CLP ( Supplemental Fig
This is normal and expected with weekly dosing
Apples: Heres the rule: Please dont peel them
Subcutaneous Drug Injection Review (PMC) Pharmacologic considerations of the subcutaneous route Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
But once patients start a GLP-1 receptor agonist, they may need to keep taking it indefinitely
Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation